Investor · Boston, MA

Malcolm Salter

Open Malcolm in the network graph →

Filings

12

SEC Form D

Connections

103

co-filers

Capital

$13.3M

across filings

Active

Jan 2022

to Apr 2024

Most-connected co-filers (103)

Noah Beerman · Boston, MA6 shared Bobby W. Sandage · St. Louis, MO5 shared Todd Kaloudis · ARLINGTON, VA5 shared Julia A. Novina · Cambridge, MA4 shared Drew Dennison · Boston, MA4 shared Ryan Cassin · Dallas, TX4 shared Alexander Doubet · Dallas, TX4 shared Andrew Magliochetti · New York, NY3 shared Craig Shesky · New York, NY3 shared Ilya Sukhar · Atlanta, GA3 shared Chris Bahl · Boston, MA3 shared Elena A. Prokupets · Cambridge, MA3 shared Mark Lewis · KENNESAW, GA3 shared Judy L. Chun · Winston-Salem, NC3 shared Charles H. Hauser · Winston-Salem, NC3 shared Theodore B. Manny · Winston-Salem, NC3 shared Richard H. Shin · Winston-Salem, NC3 shared Bryan H. Dunn · Miami, FL3 shared Linburgh C. Martin · George Town, Grand Cayman, Cayman Islands2 shared Timothy Szott · Fort Worth, TX2 shared Ezra Galston · Chicago, IL2 shared Alexander B. Lach · Los Angeles, CA2 shared Patrick L. Mckenzie · Winston-Salem, NC2 shared David Hammond · George Town, Grand Cayman, Cayman Islands2 shared

Recent filings (12)

ATROPOS HEALTH INCMay 2024 · 15 co-filers$33.0M AI Proteins, Inc.Apr 2024 · 25 co-filers$10.0M AI Proteins, Inc.Apr 2024 · 25 co-filers$10.0M Piedmont Stone Center PLLCJan 2024 · 27 co-filers$798K ATROPOS HEALTH INCAug 2023 · 15 co-filers$5.0M AI Proteins, Inc.Aug 2023 · 25 co-filers$10.0M AI Proteins, Inc.Aug 2023 · 25 co-filers$10.0M Piedmont Stone Center PLLCJan 2023 · 29 co-filers$305K Marshall Wace Funds LP - MW Japan Market Neutral Plus (US) FundJan 2023 · 18 co-filers NextRNA Therapeutics, Inc.Jan 2022 · 29 co-filers$50.0M NextRNA Therapeutics, Inc.Jan 2022 · 29 co-filers$50.0M AI Proteins, Inc.Jan 2022 · 23 co-filers$18.2M AI Proteins, Inc.Jan 2022 · 23 co-filers$18.2M Piedmont Stone Center PLLCJan 2022 · 28 co-filers$216K Marshall Wace Funds LP - MW Japan Market Neutral Plus (US) FundJan 2022 · 18 co-filers C4 Therapeutics, Inc.Jan 2016 · 24 co-filers$73.5M C4 Therapeutics, Inc.Jan 2016 · 24 co-filers$73.5M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Malcolm in the interactive graph →